{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01751",
      "entity_text" : "Abeta burden",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01719",
      "entity_text" : "Abeta antibodies",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "For example, multiple Abeta antibodies were shown to reduce Abeta burden in preclinical models and several of them have progressed to clinical trials for treating AD patients.",
  "reading_complete" : "2020-08-08T08:16:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T08:14:04Z",
  "trigger" : "reduce",
  "evidence" : [ "Abeta antibodies were shown to reduce Abeta burden" ],
  "pmc_id" : "4410967",
  "score" : 0
}